Better outcomes have been demonstrated with coronary artery bypass grafting (CABG) than with percutaneous coronary intervention (PCI) in three-vessel coronary artery disease (CAD). However, the PCIs performed in these studies were guided by angiography, not fractional flow reserve (FFR) measurements. Investigators aimed to conduct a noninferiority trial to compare FFR-guided … [Read more...] about FAME 3 noninferiority trial: FFR-guided PCI vs CABG
Cardiology research news
COAPT Trial: Renal dysfunction and cardiac outcomes in heart failure
Patients with heart failure (HF) and severe secondary mitral regurgitation (MR) frequently also suffer from baseline renal disease (RD). Renal function is further impaired by HF and MR, often accelerating progression to end-stage renal disease (ESRD), necessitating a form of renal replacement therapy (RRT). For patients with MR deemed too high-risk for surgery, the … [Read more...] about COAPT Trial: Renal dysfunction and cardiac outcomes in heart failure
Change in cognitive function in atrial fibrillation patients
Atrial fibrillation (AF) is associated with cognitive decline, even in the absence of clinical stroke. The Swiss AF Cohort (SWISS-AF) study sought to quantify the incidence of silent brain infarcts in patients with AF. Investigators then explored the relationship between silent brain infarcts and cognitive decline. Finally, they also examined if anticoagulation seemed to have … [Read more...] about Change in cognitive function in atrial fibrillation patients
EuroPCR 2022 Highlights
The EuroPCR 2022 Conference occurred from May 17 to 20, 2022, in Paris, France. The EuroPCR 2022 combined onsite and online participation seamlessly. Here is our curated list of some of the top highlights from the EuroPCR 2022 Conference presentations. ARCH trial1: Of the 708 patients (N=2,114) with acute coronary syndrome (ACS), post-percutaneous coronary intervention … [Read more...] about EuroPCR 2022 Highlights
Top Highlights of ACC 2022
The American College of Cardiology (ACC) 2022 Scientific Session was a hybrid event which took place from April 2 to 4, 2022, in Washington, USA and online. Here is the curated list of the top highlights of the ACC 2022 sessions. SODIUM-HF trial1: This international trial (NCT02012179) followed 806 adult patients with chronic heart failure (CHF) receiving optimally … [Read more...] about Top Highlights of ACC 2022